Where Regeneron appears
10 total
nofi and Regeneron will be hosting a conference call for the financial community on Praluent® (alirocumab) Injection for the treatment of high LDL cholesterol in adult patients. The conference call will take place on Friday, July 24, 2015 (...
… costs to patients will vary depending on insurance status and eligibility for patient assistance. Sanofi and Regeneron are committed to ensuring that patients in the U.S. who are prescribed Praluent are able to access the medicine and rece...
… costs to patients will vary depending on insurance status and eligibility for patient assistance. Sanofi and Regeneron are committed to ensuring that patients in the U.S. who are prescribed Praluent are able to access the medicine and rece...
…ical trial program," said Leonard S. Schleifer, M.D., Ph.D., Founder, President, and Chief Executive Officer, Regeneron. "Praluent represents the culmination of more than a decade of tireless work to translate the genetic- based discovery o...
…n't want the noise about these drugs to be price," says Leonard Schleifer, the chief executive and founder of Regeneron. "We have to make sure that people get access to the drug for a fair price if they're insured, for free if they're not i...
…e who've had heart attacks or strokes, who are already taking the maximum dose of a statin they can tolerate. Regeneron and its marketing partner Sanofi say Praluent will have a wholesale cost of $40 a day, or $14,600 a year, for either of...
…r Praluent in the European Union in September 2015. Investor Relations Conference Call on Praluent Sanofi and Regeneron will be hosting a conference call for the financial community on Praluent® (alirocumab) Injection for the treatment of h...
because Amgen and Regeneron will compete by giving the insurers rebates.
doctors expressed a preference for Praluent. One advantage of Regeneron’s drug is that doctors
Regeneron. ""Praluent represents the culmination of more than a decade of tireless work to translate the
